OSU-6162
跳至導覽
跳至搜尋
| File:OSU-6162.svg | |
| 臨床資料 | |
|---|---|
| ATC碼 |
|
| 識別資訊 | |
| |
| CAS號 | 156907-84-5 |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| E編碼 | {{#property:P628}} |
| CompTox Dashboard (EPA) |
|
| ECHA InfoCard | {{#property:P2566}}Module:EditAtWikidata第29行Lua錯誤:attempt to index field 'wikibase' (a nil value) |
| 化學資訊 | |
| 化學式 | C15H23NO2S |
| 摩爾質量 | 281.41 g·mol−1 |
| 3D模型(JSmol) | |
| |
| |
OSU-6162,也稱為PNU-96391,是一種含氮有機硫化合物,化學式C
15H
23NO
2S,結構上與普利多匹定(PL-101)類似,區別在於OSU-6162為3-苯基哌啶結構,而PL-101為4-苯基哌啶結構。OSU-6162可作為多巴胺受體D2和5-HT2A受體的部分激動劑[1][2][3]。
參考文獻[編輯]
- ↑ Ekesbo A, Andrén PE, Gunne LM, Tedroff J. (-)-OSU 6162 inhibits levodopa-induced dyskinesias in a monkey model of Parkinson's disease. NeuroReport. July 1997, 8 (11): 2567–70. PMID 9261828. S2CID 29806568. doi:10.1097/00001756-199707280-00029.
- ↑ Tedroff J, Torstenson R, Hartvig P, Sonesson C, Waters N, Carlsson A, et al. Effects of the substituted (S)-3-phenylpiperidine (-)-OSU6162 on PET measurements in subhuman primates: evidence for tone-dependent normalization of striatal dopaminergic activity. Synapse. April 1998, 28 (4): 280–7. PMID 9517836. S2CID 2090820. doi:10.1002/(SICI)1098-2396(199804)28:4<280::AID-SYN3>3.0.CO;2-5.
- ↑ Tedroff J, Ekesbo A, Sonesson C, Waters N, Carlsson A. Long-lasting improvement following (-)-OSU6162 in a patient with Huntington's disease. Neurology. October 1999, 53 (7): 1605–6. PMID 10534281. doi:10.1212/wnl.53.7.1605.